About our project

The problem we solve: cliexa addresses three key aspects of chronic disease management that are inherently flawed in the healthcare system: the relationships between clinicians, payors and patients. In a recent Becker’s Hospital Review, it was found that half of physicians' average workdays are spent entering data into EHRs and conducting clerical work, while just 27 percent of their workdays are spent with patients. Care providers continue to face regulatory and workflow challenges, payors look for justification of cost, while patients have difficulty tracking their disease activity and medication history. A continual trend of ineffective tools and cumbersome implementation have restricted physicians and hospitals from fully leveraging and realizing the clinical and financial benefits of patient-reported data.

About our solution: cliexa provides a platform that improves quality of care, clinical workflow, income generation, time spent with patients, while reducing liability concerns. Patients will play a greater role in their care with cliexa and will be able to make valuable correlations to causative factors for pain flare-ups through remotely reported outcomes. The discrete clinical data and patient reported outcomes enable providers to improve clinical decision making, while reducing liability and billing concerns with payors. These algorithms help providers respond more efficiently to new data so their patients will have fewer complications or side effects. Payors will be provided with longitudinal data to better understand necessary treatment decisions and patient status. This will lead to improved communication and greater efficiency in the billing process, while expanding the understanding of clinical processes that support patient well-being for future coverage improvements.

Progress to date:

Our six applications have been successfully implemented in clinics across Colorado, and we have secured instrumental partnerships with organizations such as the American College of Cardiology and Kaiser Permanente. The development of our cardiology platform is nearing the final stages, with the connection to wearable devices being the final obstacle to overcome in the commercialization of cliexa-PULSE. We are currently commercialized in four clinics and piloting at another four.

Earlier in 2018, we carried out a case study in a rheumatology clinic to identify how screening and monitoring of Rheumatoid Arthritis patients through our customized RA platform. The results we saw were significantly reassuring: 85% of patients said they would recommend cliexa forms to other clinicians, cliexa-RA scored an average of 3.57 out of 4 when compared to paper in ease of use, 3.61 in patient-reported reduction of time spent, and 3.50 when asked how easy the platform was to understand.

About Our Company

How We Help Patients

We have identified the following concerns of patients with patient reported outcomes: the burden of the questionnaire, frequency of data collection, location for completion, appropriate literacy level, physical/cognitive impairment, privacy concerns, value to “me”, and uncertainty of use by clinicians. cliexa addresses these concerns through the ease of our platform. The tool allows patients to track their disease status, medications, symptoms and complications over time, providing the opportunity to identify correlating factors both clinically and environmental. Our engagement, functionality, aesthetics and reported outcomes collected through our platform give patients empowerment over their chronic disease management for improved care.

How We Help Physicians

cliexa provides a tool that improves quality of care, clinical workflow, income generation, time spent with patients, while reducing liability concerns. For physicians, discrete clinical data and patient reported outcomes enable them to improve clinical decision making, while reducing liability and billing concerns with payors. These algorithms also help providers respond more efficiently to new data, so their patients will have fewer complications or side effects. Payors will be provided with longitudinal data to better understand necessary treatment decisions and patient status. This will lead to improved communication and greater efficiency in the billing process, while expanding the understanding of clinical processes that support patient well-being for future coverage improvements. Patients will play a greater role in their care with cliexa and will be able to make valuable correlations to causative factors for pain flare-ups for example. cliexa enables care teams to have a more comprehensive view on their patients’ disease activity. Patient-reported outcomes with cliexa’s assessment models assist providers in making more informed decisions about treatment plans and enable them to respond more quickly to new data so their patients will have fewer complications or side effects. cliexa streamlines processes and increases clinical efficiency, while also providing opportunities for greater revenue streams that benefit the patient.

How We Help Hospitals

There are several digital health platforms supporting physicians and patients. However, the key concerns when implementing any new technology tool are cost, time required, and applicable functionality. cliexa stands out from the existing market by offering seamless EMR integration of customizable assessments to the providers preferences. cliexa's innovative technology provides a HIPAA compliant framework that is fully customizable across a variety of disease states and treatment settings. The implementation process or customization can be done in a matter of days as compared to the 6-9 month waiting period it requires to make custom changes to EHR systems. This is all done through a payment model that supports under-utilized clinical reimbursements, therefore increasing revenues beyond the cost of the product. cliexa collects this data and then integrates it into existing EMR systems securely, allowing clinicians to compare the treatment and medication histories. Instead of competing with EMR systems, cliexa offers add-ons for chronic disease specific areas for healthcare management, as seen in the most recent integration with Greenway Health EHR system and cliexa’s EPIC App Orchard Marketplace participation. Additionally, cliexa's tools provide access to the information needed for tracking patient and physician compliance. These functions lead to a reduction in compliance issues, saving time and money for healthcare systems by maximizing reimbursements and reducing compliance risks.

How We Help Partners

Our partnering strategy has been to target large and small entities across the United States, including the American College of Cardiology, Kaiser Permanente, Maine Medical Center, National Mental Health Innovation Center at CU Anschutz Medical Center, UC Health, and many more. We continue to push for further partnerships across all specializations that cliexa can reach by growing personal relationships and increasing our exposure at national conferences. These partnerships have been critical in our growth and development as a startup and will continue to be vital to expanding our network in these upcoming years. We view partnerships as a path to diversify our image and product to find a way to fit into all the niches of the healthcare industry. With the inherent customizability of our application, we have been able to integrate with specialties such as rheumatology, gastroenterology, chronic pain, primary care, mental health, and cardiovascular disease. These do not serve as limitations, but rather as a foundation, as we expand as a company to address the issues in the healthcare industry across all specialties.

Challenge Mission

Innovation Details

Intellectual Property Summary

• C130070/A001 Disease Management System with Evidence-Based Data Indexing - Patent Pending

• 3211-03-PR-EFS-CS Multi-dimensional Pain Assessment - jointly filed with University of Colorado Boulder - Patent Pending

 

Clinical Information

A 2017 study conducted by the American Hospital Association (AHA) revealed the issues surrounding compliance and billing in the healthcare field. Roughly $39 billion was spent annually on regulatory compliance in the United States, with $760,000 per hospital being spent on additional health IT investments to support regulatory compliance. On average, hospitals spent about $1.6 million each year on billing and coverage verification rather than directing it towards investment in modern techniques to improve the digital healthcare process. Cost-measures aside, the average size hospital dedicates 59 full-time employees to regulatory compliance, over 1/4 of which are doctors and nurses. Compliance and billing not only drains money, but also time that the providers could be spending with patients. cliexa addresses this compliance issue in conjunction with providing patients and physicians a tool to unleash the power of patient reported data in their system.

https://www.aha.org/system/files/2018-02/regulatory-overload-report.pdf

cliexa is not considered a medical device, and therefore does not need any FDA approvals or costs expected at this time.

Regulatory Status

cliexa has already received 513g verification from FDA for disease management protocols and evidence-based data indexing concepts. There are no FDA regulatory costs expected at this time. There are expected costs for HIPAA and IT security related enhancements. 

How we will use the funds raised

The funding and grants from this program will be used to overcome the final obstacles in linking our platform with wearable devices that provide critical information that can be utilized by providers to gather a larger understanding of their patients history and symptoms over a longer period of time rather than the span of days before they attend their appointment. The money will specifically be used to integrate with IoT devices and to upkeep our lead developer to produce the proper code to ensure this is incorporated seamlessly into our cliexa platform as well as integrating wearables into our other six platforms that are currently developed and functioning in clinics around Colorado. Perhaps the most influential aspect of this grant would be to unleash our product into the surrounding areas of New Orleans, providing our company traction in an emerging market and a chance to address specific needs of providers and patients in that region. 

Thank You

cliexa is at the critical point where exposure to clients and investors is more valuable that immediate revenue gain. Our product has been successfully implemented in clinics across Colorado, and we have secured instrumental partnerships with organizations such as the American College of Cardiology and Kaiser Permanente. These partnerships and pilots with larger institutions have proven that we are unique in the digital health sector. The most valuable aspect to our growth in the upcoming months will be increasing our exposure as an innovative company in the digital health industry and expanding to various markets across the country. Please contact us for further information on how we are striving to make a dent in the healthcare industry.

Investor Info

Market Size

cliexa addresses multiple specialties in the healthcare system ranging from primary care to chronic care management, and encompassing everything in between. The strongest aspect of cliexa is the customizability to each specialty whether in a clinic or hospital. In Colorado alone, there are 15,422 physicians practicing our target specialties with an average of 359 patients per physician according to AMA Physician Masterfile using 2016 US Census data. This value is even more staggering nationwide at 860,939 physicians practicing in our target areas with an average of 373 patients per physician. According to this same Census, there are 953,695 allopathic and osteopathic physicians in the United States with a total healthcare spending of $3.4 trillion in 2016 as estimated by CMS. Due to these numbers based on the 2016 data, we can assume that our total market value is roughly $3.06 trillion. The projects have skyrocketed since 2016 for investment in Healthcare IT, total spending in the healthcare system, and the number of people being affected in our target areas increase as well. Newest projections on the healthcare market predict that global healthcare spending will increase to $8.734 trillion by 2020 according to research from The Economist Intelligence Unit as described by Deloitte. The Healthcare IT sector is rapidly expanding, and cliexa is in an optimal position to take the healthcare system by storm in the coming years.

"Data and Reports - Workforce - Data and Analysis - AAMC." Association of American Medical Colleges. Accessed January 04, 2019. https://www.aamc.org/data/workforce/reports/458480/1-1-chart.html.

"Just How Big Is The Healthcare Industry? Here's What You Need to Know." Dreamit. April 24, 2018. Accessed January 04, 2019. https://www.dreamit.com/journal/2018/4/24/size-healthcare-industry.

Young, Aaron, Humayun J. Chaudhry, et al. "A Census of Actively Licensed Physicians in the United States, 2016." Journal of Medical Regulation 103, no. 2 (2017): 7-21. doi: 10.30770/2572-1852-103.2.7.

Projected 3 Year Growth

cliexa has a modular mobile front-end and HIPAA compliant Cloud Infrastructure with Integration services that can be configured for any specialty to collect digital data and integrate with any EMR using HL7/FIHR or file services. With the recent partnership with American College of Cardiology, cliexa plans to implement multiple disease tracking platform including medical device and claims data into member institutions and sign new health systems for Platform-As-A-Service model and grow the business up to $20 MM revenues annually by the end of 2022.

Revenue Model

With cliexa’s unique business model, clinicians are provided reimbursement guidance for the services rendered, opening a per patient reimbursement potential of $35-$150 per month for already rendered services. Clinics can choose between a $10 per patient per month option that includes our fully integrated platform or strictly digital intake forms at $1 per form. Through this model, cliexa strengthens revenue streams with discrete data to support clinical decisions. 

Competitors

Our top three competitors addressing issues similar to ours are Optum, Outcomes.com, and Mentegram. These companies are similar to cliexa since they focus on remote patient monitoring through seamless EMR integration, pushing disease activity scores directly to the system. What differentiates us from our competitors are customizable, clinically validated add-on assessments integrated into our platforms. These assessments enable patient reported outcomes to be filled out remotely and send disease activity scores directly to their provider for review and to push onwards to their specific EMR system. We provide the assessments directly for providers and are able to customize the structure and layout on our platform to their preference. This, alongside our modular application framework, is what separates cliexa from our competitors in the digital health market.

Traction

Current pilots with most likely targeted to become paying clients within Q2 2019:
Kaiser Permanente Rock Creek Rheumatology Clinic
Mednow Primary Care Clinic (3 Clinics)
Colorado Pain Care (4 Clinics)
DTC Family Practice - Health One (3 Clinics)
Paying customers:
New Health Services Pain and Behavioral Health
UCHealth Longmont Primary Care and Pediatrics
Colorado Arthritis Center
Anderson Podiatry Center as of January 2019
Partnerships:
American College of Cardiology (Innovation Collaborator, Investor)
Kaiser Permanente (Innovation Partner, Investor through Colorado Permanente Medical Group)
National Mental Health Innovation Center (Innovation Collaborator)
University of Colorado Boulder (Research Collaboration Agreement with jointly filed IP)
University of Virginia (Research Collaboration)
University of Northern Colorado (Research Collaboration)
Maine Medical Center (Innovation Collaborator)

Due Diligence Docs

Please note that access to the company's confidential materials is limited. Click this button to request access from the Company and its representatives.

Send access request

---

Supporters

• 
  Dr Norman Goldwasser
  05/07/2019 - Liked the project.
• 
  Linda Stotsky
  02/11/2019 - Liked the project.

Comments

Login to post your comment!
Click here to Login

Updates

No updates found .